What AngioConsult does

AngioConsult GmbH is a privately held healthcare consulting firm headquartered in Speyer, Germany, founded in 2001. The firm specializes in guiding medical device and healthcare innovation companies from concept through commercialization, with a particular focus on the cardiovascular, structural heart, vascular surgery, and radiology/angiology verticals. AngioConsult operates through three integrated business units: Business & Therapy Development (BTD) provides strategic advisory and operational support covering startup management, fundraising, reimbursement strategy, CE/FDA regulatory approvals, clinical studies, and market analysis; the Innovation unit incubates early-stage healthcare concepts with internal capital and resources (portfolio projects include the MeineKlinik physician communication app and the European launch of Hawthorne Effect clinical trial follow-up services); and Commercialization leverages a core partnership with Angiopro, a DACH-region medical device distributor with 25+ years of channel experience.

The company generates revenue through project-based professional services engagements, with pricing not publicly disclosed and contracts tailored to individual client needs. Its go-to-market combines direct enterprise consulting with channel partnerships, targeting two primary customer segments: medical device companies seeking European market entry and early-stage healthcare innovation startups requiring formation, funding, and commercialization support. The firm is led by founders Hanns-Joachim Rieck (Chairman) and Benjamin Rieck (CEO), supported by a team of 11-50 employees organized into specialized verticals. AngioConsult reports 81+ completed projects and 15 client company exits over 12+ active years, though revenue figures are not publicly disclosed and the company has no external institutional funding.

Name

AngioConsult

Legal name

AngioConsult GmbH

Website

https://angioconsult.de

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

AngioConsult GmbH is a German healthcare consulting firm that guides medical device and healthcare innovation companies from concept to commercialization, specializing in cardiovascular, structural heart, and vascular surgery verticals through strategic advisory, operational support, and DACH-region distribution partnerships.

Ownership category

akta.pro rank

Headquarters

HQ city

Speyer

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Strategic Consulting Services: AngioConsult provides strategic advisory services including company startup support, fundraising consulting, reimbursement strategy, market research, and commercialization strategy. Services are tailored to medical device and healthcare innovation companies seeking to enter the European market.
2. Operational Support Services: The company offers operational support including European market analyses, clinical case support, marketing activities, distribution management, software implementation, and exhibitions/congresses management. These are project-based professional services supporting the full product lifecycle from market entry to commercialization.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

AngioConsult provides end-to-end consulting and business development services for medical device and healthcare innovation companies, spanning company formation, fundraising, regulatory approval (CE/FDA), clinical trial management, market analysis, reimbursement strategy, and commercial launch support. The firm operates three service units — Business & Therapy Development (strategic advice and operational support), the Innovation Unit (early-stage project development into commercial ventures), and Commercialization (via DACH-region distribution partner Angiopro). Services are project-based and delivered to enterprise clients in the cardiovascular, structural heart, vascular surgery, and radiology/angiology segments.

Product overview

AngioConsult is a healthcare consulting firm offering three integrated service units: (1) Business & Therapy Development (BTD) provides strategic advice and operational support for medical device commercialization, covering startup management, regulatory approval (CE/FDA), clinical studies, marketing, and distribution; (2) Innovation Unit develops early-stage healthcare concepts and software products through company founding, investment, and market validation, including the MeineKlinik communication app and Hawthorne Effect clinical trial follow-up service; (3) Commercialization through core partner Angiopro for DACH region distribution of cardiology, vascular surgery, and radiology products. The portfolio spans the full product lifecycle from concept to market launch.

Differentiator

Problem solved

Functional benefit

Brands

• Business & Therapy Development: Consulting unit providing strategic and operational support for therapy development from patent to commercialization, including market analysis, clinical studies, CE/FDA approvals, and reimbursement strategies.
• Innovation

Quantifiable outcome

• 15 successful company exits achieved through their guidance and support
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• AngioprocoreChannel Partner/ Reseller/ DistributorAngiopro is AngioConsult's core distribution partner for the DACH region, with over 25 years of experience distributing medical devices and software products. The partnership covers cardiology, vascular surgery, and radiology/angiology specialties. Angiopro operates from angiopro.de and represents a key component of AngioConsult's go-to-market strategy, enabling clients to access established sales channels in Germany, Austria, and Switzerland.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Health Advances: Specialized healthcare strategy consulting firm focused on medtech, diagnostics, and digital health commercialization and market access—closely mirrors AngioConsult's medical device commercialization advisory offering.
• Alacrita Consulting: Specialist life sciences consulting firm supporting biotech, medtech and digital health companies with strategy, market access, and commercialization—closely comparable boutique competitor to AngioConsult in Europe.
• Alira Health: Global medtech and life sciences consulting + advisory firm that supports medical device and digital health companies across product development, regulatory, clinical, and commercialization—directly comparable to AngioConsult's BTD service stack in the European medtech space.

Broad incumbents

• McKinsey & Company (Healthcare Practice): Global strategy leader with deep medtech and pharma practice supporting market entry, regulatory strategy, and commercial excellence; a major competitive incumbent to niche European medtech commercialization consultancies like AngioConsult.
• Boston Consulting Group (Healthcare): Global management consulting firm with a substantial medtech and healthcare practice that competes for the same European market entry and commercialization mandates AngioConsult pursues.
• L.E.K. Consulting: Global strategy consulting firm with a large healthcare and medtech practice advising on market entry, commercial strategy, and M&A; broader portfolio of clients and capabilities than AngioConsult but addresses identical medtech commercialization decision points.
• Simon-Kucher & Partners: Global consulting leader in pricing, market access, and commercial strategy with deep healthcare and medtech practices; competes with AngioConsult on reimbursement strategy and commercialization planning for medtech innovators.
• ZS Associates: Large global consulting firm with significant European healthcare and medtech commercial strategy practice; overlaps with AngioConsult on go-to-market strategy, market access and sales/distribution advisory for medical device companies.
• Bain & Company (Healthcare): Top-tier global consultancy with healthcare and medtech teams advising on strategy, commercial launches, and post-merger integration; addresses the same medtech market access and commercialization work as AngioConsult.

Emerging players

• MedTech Strategic Advisors: Niche medtech-focused consultancy offering market development, commercialization strategy and partnership advisory for medical device innovators; comparable in scale and Europe-centric footprint to AngioConsult.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/angio-consult-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AngioConsult